← Back to Patent Explorer
US5922753A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods for treating bone deficit conditions with benzothiazole

Assignee: OsteoScreen Inc
•
Filing: 1997-02-28
•
Granted: 1999-07-13
•
Expires: 2017-02-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds containing two aromatic systems covalently linked through a linker containing one or more atoms, or "linker" defined as including a covalent bond per se so as to space the aromatic systems at a distance 1.5-15 Å, are effective in treating conditions associated with bone deficits. The compounds can be administered to vertebrate subjects alone or in combination with additional agents that promote bone growth or that inhibit bone resorption. They can be screened for activity prior to administration by assessing their ability to effect the transcription of a reporter gene coupled to a promoter associated with a bone morphogenetic protein and/or their ability to stimulate calvarial growth in model animal systems.

Inventors

  • 👤 Charles Petrie
  • 👤 Mark W. Orme
  • 👤 Nand Baindur
  • 👤 Kirk G. Robbins
  • 👤 Laurence H. Hurley
  • 👤 Sean M. Kerwin
  • 👤 Gregory R. Mundy

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 01:59
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/41; A61K31/425; A61K31/428; A61K31/4164; A61K31/4184

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 84 words
A method to treat a condition in a vertebrate animal characterized by a deficiency in, or need for, bone growth replacement and/or an undesirable level of bone resorption, which method comprises administering to a vertebrate subject in need of such treatment an effective amount of a compound of the formula: ##STR5## wherein each R 1 and R 2 is independently a non-interfering substituent; m is an integer of 0-4; the dotted line represents an optional π bond; and L is a flexible non-conjugating linker.
Claim 2
Independent Claim 84 words
A method to treat a condition in a vertebrate animal characterized by a deficiency in, or need for, bone growth replacement and/or an undesirable level of bone resorption, which method comprises administering to a vertebrate subject in need of such treatment an effective amount of a compound of the formula: ##STR5## wherein each R 1 and R 2 is independently a non-interfering substituent; m is an integer of 0-4; the dotted line represents an optional π bond; and L is a flexible non-conjugating linker.
Claim 3
Dependent Claim 24 words
The method of claim 1 wherein L is selected from the group consisting of --NRCO-- and --CONR--, wherein R is H or alkyl (1-6C).
Claim 4
Dependent Claim 22 words
The method of claim 1 wherein R 2 is --NR 2 or --OR where each R is independently H or alkyl (1-6C).
Claim 5
Dependent Claim 20 words
The method of claim 1 wherein said compound is selected from the group consisting of Compound Nos. 59-0102 and 59-0070.
Claim 6
Dependent Claim 36 words
The method of claim 1 wherein said condition is osteoporosis, bone fracture or deficiency, primary or secondary hyperparathyroidism, periodontal disease or defect, metastatic bone disease, osteolytic bone disease, post-plastic surgery, post-prosthetic joint surgery, or post-dental implantation.
Claim 7
Dependent Claim 25 words
The method of claim 1 which further comprises administering to said subject one or more agents that promote bone growth or that inhibit bone resorption.
Claim 8
Dependent Claim 30 words
The method of claim 6 wherein said agents are selected from the group consisting of bone morphogenetic factors, anti-resorptive agents, osteogenic factors, cartilage-derived morphogenic proteins, growth hormones, and differentiating factors.

References Cited (Backward Citations)

WO1993010113A1 Cited
US5280040A Cited
WO1995010513A1 Cited
US5441964A Cited
US5523309A Cited
US5622974A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-07-12 2003-01-11 2003-07-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-07-12 2007-01-11 2007-07-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-07-12 2011-01-11 2011-07-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag